Who is the Top Investor In Alkermes plc (ALKS)?

Alkermes plc (NASDAQ: ALKS) is -3.50% lower on its value in year-to-date trading and has touched a low of $20.46 and a high of $31.34 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ALKS stock was last observed hovering at around $26.70 in the last trading session, with the day’s gains setting it 0.07%.

Currently trading at $26.77, the stock is -3.16% and -1.65% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.0 million and changing 0.26% at the moment leaves the stock -0.56% off its SMA200. ALKS registered 5.95% gain for a year compared to 6-month gain of 2.66%. The firm has a 50-day simple moving average (SMA 50) of $2.49 and a 200-day simple moving average (SMA200) of $12.57.

Invest Like Buffett: Travel Back in Time & Grab This High-Potential Stock Before It Explodes

Imagine buying Apple for $1, Amazon for $2, or Tesla for $3. Now, imagine the same opportunity with a hidden gem trading under $3 right now.

Our premium newsletter, powered by AI and expert analysis, uncovers these time-travel investment opportunities.

Invest like Buffett and profit from undervalued gems before the market catches on.

Limited-time offer: Get your first month for just $2.90 and start your journey to wealth creation.


The stock witnessed a -7.63% loss in the last 1 month and extending the period to 3 months gives it a 14.05%, and is -0.63% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.97% over the week and 2.22% over the month.

Alkermes plc (ALKS) has around 2280 employees, a market worth around $4.47B and $1.59B in sales. Current P/E ratio is 21.69 and Fwd P/E is 11.15. Profit margin for the company is 13.50%. Distance from 52-week low is 30.84% and -14.57% from its 52-week high. The company has generated returns on investments over the last 12 months (12.47%).

Alkermes plc quarterly earnings per share for the current quarter are estimated at $0.51 with sales reaching $362.02M over the same period.The EPS is expected to grow by 405.71% this year, but quarterly earnings will post 48.30% year-over-year. Quarterly sales are estimated to grow 67.50% in year-over-year returns.

448 institutions hold shares in Alkermes plc (ALKS), with institutional investors hold 106.00% of the company’s shares. The shares outstanding are 164.38M, and float is at 164.25M with Short Float at 8.05%. Institutions hold 104.64% of the Float.

The top institutional shareholder in the company is Vanguard Group Inc with over 18.59 million shares valued at $582.01 million. The investor’s holdings represent 11.16% of the ALKS Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 16.89 million shares valued at $528.64 million to account for 10.14% of the shares outstanding. The other top investors are Sarissa Capital Management, LP which holds 14.04 million shares representing 8.43% and valued at over $439.45 million, while Wellington Management Group, LLP holds 4.62% of the shares totaling 7.69 million with a market value of $240.72 million.

Alkermes plc (ALKS) Insider Activity

A total of 0 insider transactions have happened at Alkermes plc (ALKS) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider sale by LAURENCIN CATO T, the company’s Director. SEC filings show that LAURENCIN CATO T sold 2,638 shares of the company’s common stock on Jun 08 at a price of $31.85 per share for a total of $84020.0. Following the sale, the insider now owns 7479.0 shares.

Alkermes plc disclosed in a document filed with the SEC on Jun 07 that LAURENCIN CATO T (Director) sold a total of 2,800 shares of the company’s common stock. The trade occurred on Jun 07 and was made at $31.50 per share for $88200.0. Following the transaction, the insider now directly holds 7479.0 shares of the ALKS stock.

Still, SEC filings show that on May 30, Nichols Christian Todd (SVP, Chief Commercial Officer) disposed off 27,134 shares at an average price of $28.93 for $0.78 million. The insider now directly holds 40,984 shares of Alkermes plc (ALKS).

Alkermes plc (ALKS): Who are the competitors?

One of the company’s main competitors (and peers) include AstraZeneca PLC ADR (AZN) that is trading -7.78% down over the past 12 months.Johnson & Johnson (JNJ) lies in the list of competitors of the Alkermes plc and is -3.55% lower over the same period from ALKSSanofi ADR (SNY) is -2.06% down on the 1-year trading charts.